244 related articles for article (PubMed ID: 24425048)
1. microRNA-148a is a prognostic oncomiR that targets MIG6 and BIM to regulate EGFR and apoptosis in glioblastoma.
Kim J; Zhang Y; Skalski M; Hayes J; Kefas B; Schiff D; Purow B; Parsons S; Lawler S; Abounader R
Cancer Res; 2014 Mar; 74(5):1541-53. PubMed ID: 24425048
[TBL] [Abstract][Full Text] [Related]
2. miR-148a is upregulated by Twist1 and T-bet and promotes Th1-cell survival by regulating the proapoptotic gene Bim.
Haftmann C; Stittrich AB; Zimmermann J; Fang Z; Hradilkova K; Bardua M; Westendorf K; Heinz GA; Riedel R; Siede J; Lehmann K; Weinberger EE; Zimmel D; Lauer U; Häupl T; Sieper J; Backhaus M; Neumann C; Hoffmann U; Porstner M; Chen W; Grün JR; Baumgrass R; Matz M; Löhning M; Scheffold A; Wittmann J; Chang HD; Rajewsky N; Jäck HM; Radbruch A; Mashreghi MF
Eur J Immunol; 2015 Apr; 45(4):1192-205. PubMed ID: 25486906
[TBL] [Abstract][Full Text] [Related]
3. Novel anti-apoptotic microRNAs 582-5p and 363 promote human glioblastoma stem cell survival via direct inhibition of caspase 3, caspase 9, and Bim.
Floyd DH; Zhang Y; Dey BK; Kefas B; Breit H; Marks K; Dutta A; Herold-Mende C; Synowitz M; Glass R; Abounader R; Purow BW
PLoS One; 2014; 9(5):e96239. PubMed ID: 24805821
[TBL] [Abstract][Full Text] [Related]
4. NF-κB induces miR-148a to sustain TGF-β/Smad signaling activation in glioblastoma.
Wang H; Pan JQ; Luo L; Ning XJ; Ye ZP; Yu Z; Li WS
Mol Cancer; 2015 Feb; 14():2. PubMed ID: 25971746
[TBL] [Abstract][Full Text] [Related]
5. MiR-148a inhibits the proliferation and migration of glioblastoma by targeting ITGA9.
Xu TJ; Qiu P; Zhang YB; Yu SY; Xu GM; Yang W
Hum Cell; 2019 Oct; 32(4):548-556. PubMed ID: 31489579
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
[TBL] [Abstract][Full Text] [Related]
7. MiR-330-mediated regulation of SH3GL2 expression enhances malignant behaviors of glioblastoma stem cells by activating ERK and PI3K/AKT signaling pathways.
Yao Y; Xue Y; Ma J; Shang C; Wang P; Liu L; Liu W; Li Z; Qu S; Li Z; Liu Y
PLoS One; 2014; 9(4):e95060. PubMed ID: 24736727
[TBL] [Abstract][Full Text] [Related]
8. miR-491-5p-induced apoptosis in ovarian carcinoma depends on the direct inhibition of both BCL-XL and EGFR leading to BIM activation.
Denoyelle C; Lambert B; Meryet-Figuière M; Vigneron N; Brotin E; Lecerf C; Abeilard E; Giffard F; Louis MH; Gauduchon P; Juin P; Poulain L
Cell Death Dis; 2014 Oct; 5(10):e1445. PubMed ID: 25299770
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of miRNA-148a inhibits proliferation, invasion, and migration while promoting apoptosis of cervical cancer cells by down-regulating RRS1.
Zhang Y; Sun B; Zhao L; Liu Z; Xu Z; Tian Y; Hao C
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30910849
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.
Chen X; Dong C; Law PT; Chan MT; Su Z; Wang S; Wu WK; Xu H
Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353
[TBL] [Abstract][Full Text] [Related]
11. miR-92a is a critical regulator of the apoptosis pathway in glioblastoma with inverse expression of BCL2L11.
Niu H; Wang K; Zhang A; Yang S; Song Z; Wang W; Qian C; Li X; Zhu Y; Wang Y
Oncol Rep; 2012 Nov; 28(5):1771-7. PubMed ID: 22895567
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA LPP-AS2 promotes glioma tumorigenesis via miR-7-5p/EGFR/PI3K/AKT/c-MYC feedback loop.
Zhang X; Niu W; Mu M; Hu S; Niu C
J Exp Clin Cancer Res; 2020 Sep; 39(1):196. PubMed ID: 32962742
[TBL] [Abstract][Full Text] [Related]
13. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
Shi L; Xi J; Xu X; Peng B; Zhang B
Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
[TBL] [Abstract][Full Text] [Related]
14. BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations.
Costa DB; Halmos B; Kumar A; Schumer ST; Huberman MS; Boggon TJ; Tenen DG; Kobayashi S
PLoS Med; 2007 Oct; 4(10):1669-79; discussion 1680. PubMed ID: 17973572
[TBL] [Abstract][Full Text] [Related]
15. MiR-143 enhances the antitumor activity of shikonin by targeting BAG3 expression in human glioblastoma stem cells.
Liu J; Qu CB; Xue YX; Li Z; Wang P; Liu YH
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):105-12. PubMed ID: 26541455
[TBL] [Abstract][Full Text] [Related]
16. MiR-148a increases glioma cell migration and invasion by downregulating GADD45A in human gliomas with IDH1 R132H mutations.
Cui D; Sajan P; Shi J; Shen Y; Wang K; Deng X; Zhou L; Hu P; Gao L
Oncotarget; 2017 Apr; 8(15):25345-25361. PubMed ID: 28445981
[TBL] [Abstract][Full Text] [Related]
17. MiR-25 regulates apoptosis by targeting Bim in human ovarian cancer.
Zhang H; Zuo Z; Lu X; Wang L; Wang H; Zhu Z
Oncol Rep; 2012 Feb; 27(2):594-8. PubMed ID: 22076535
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-566 activates EGFR signaling and its inhibition sensitizes glioblastoma cells to nimotuzumab.
Zhang KL; Zhou X; Han L; Chen LY; Chen LC; Shi ZD; Yang M; Ren Y; Yang JX; Frank TS; Zhang CB; Zhang JX; Pu PY; Zhang JN; Jiang T; Wagner EJ; Li M; Kang CS
Mol Cancer; 2014 Mar; 13():63. PubMed ID: 24650032
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-135a regulates NHE9 to inhibit proliferation and migration of glioblastoma cells.
Gomez Zubieta DM; Hamood MA; Beydoun R; Pall AE; Kondapalli KC
Cell Commun Signal; 2017 Dec; 15(1):55. PubMed ID: 29268774
[TBL] [Abstract][Full Text] [Related]
20. miR-148a promotes plasma cell differentiation and targets the germinal center transcription factors Mitf and Bach2.
Porstner M; Winkelmann R; Daum P; Schmid J; Pracht K; Côrte-Real J; Schreiber S; Haftmann C; Brandl A; Mashreghi MF; Gelse K; Hauke M; Wirries I; Zwick M; Roth E; Radbruch A; Wittmann J; Jäck HM
Eur J Immunol; 2015 Apr; 45(4):1206-15. PubMed ID: 25678371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
